Trials / Completed
CompletedNCT00851227
Study to Compare Conivaptan in Subjects With Mild & Moderate Liver Impairment Versus Subjects With Normal Liver Function
A Phase 1, Open-Label Study to Assess the Effect of Hepatic Impairment on the Pharmacokinetics of Intravenous Conivaptan
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 26 (actual)
- Sponsor
- Cumberland Pharmaceuticals · Industry
- Sex
- All
- Age
- 30 Years – 70 Years
- Healthy volunteers
- Accepted
Summary
A study to compare a 48-hour continuous infusion of conivaptan in subjects with mild and moderate liver impairment versus subjects with normal liver function
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | conivaptan hydrochloride | intravenous |
Timeline
- Start date
- 2009-02-01
- Primary completion
- 2010-01-01
- Completion
- 2010-01-01
- First posted
- 2009-02-25
- Last updated
- 2014-05-02
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00851227. Inclusion in this directory is not an endorsement.